Literature DB >> 19796713

Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.

Karsten Niefind1, Olaf-Georg Issinger.   

Abstract

At the first glance CK2alpha, the catalytic subunit of protein kinase CK2, is a rigid molecule: in contrast to many eukaryotic protein kinases in CK2alpha the canonical regulatory key elements like the activation segment occur exclusively in their typical active conformations. This observation fits well to the constitutive activity of the enzyme, meaning, its independence from phosphorylation or other characteristic control factors. Most CK2alpha structures are based on the enzyme from Zea mays, supplemented by an increasing number of human CK2alpha structures. In the latter a surprising plasticity of important ATP-binding elements - the interdomain hinge region and the glycine-rich loop - was discovered. In fully active CK2alpha the hinge region is open and does not anchor the ATP ribose, but alternatively it can adopt a closed conformation, form hydrogen bonds to the ribose moiety and thus retract the gamma-phospho group from its functional position. In addition to this partially inactive state human CK2alpha was recently found in a fully inactive conformation. It is incompatible with ATP-binding due to a combination of a closed hinge and a collapse of the glycine-rich loop into the ATP cavity. These conformational transitions are apparently correlated with the occupation state of a remote docking site located at the interface to the non-catalytic subunit CK2beta: if CK2beta blocks this site, the fully active conformation of CK2alpha is stabilized, while the binding of certain small molecule seems to favour the partially and fully inactive states. This observation may be exploited to design effective and selective CK2 inhibitors. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796713     DOI: 10.1016/j.bbapap.2009.09.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Protein structural ensembles are revealed by redefining X-ray electron density noise.

Authors:  P Therese Lang; James M Holton; James S Fraser; Tom Alber
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-20       Impact factor: 11.205

2.  Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.

Authors:  Nils Bischoff; Jennifer Raaf; Birgitte Olsen; Maria Bretner; Olaf-Georg Issinger; Karsten Niefind
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

Review 3.  Structural and functional determinants of protein kinase CK2α: facts and open questions.

Authors:  Roberto Battistutta; Graziano Lolli
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

4.  Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.

Authors:  Janeen H Trembley; Gretchen M Unger; Vicci L Korman; Diane K Tobolt; Zygmunt Kazimierczuk; Lorenzo A Pinna; Betsy T Kren; Khalil Ahmed
Journal:  Cancer Lett       Date:  2011-10-12       Impact factor: 8.679

5.  Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.

Authors:  Aurélie Gouron; Anne Milet; Helene Jamet
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

6.  Drosophila mbm is a nucleolar myc and casein kinase 2 target required for ribosome biogenesis and cell growth of central brain neuroblasts.

Authors:  Anna Hovhanyan; Eva K Herter; Jens Pfannstiel; Peter Gallant; Thomas Raabe
Journal:  Mol Cell Biol       Date:  2014-03-10       Impact factor: 4.272

7.  Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.

Authors:  Janeen H Trembley; Gretchen M Unger; Omar Cespedes Gomez; J Abedin; Vicci L Korman; Rachel I Vogel; Gloria Niehans; Betsy T Kren; Khalil Ahmed
Journal:  Mol Cell Pharmacol       Date:  2014

8.  Crystal structure of Arabidopsis thaliana casein kinase 2 α1.

Authors:  Manon Demulder; Lieven De Veylder; Remy Loris
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-04-06       Impact factor: 1.056

9.  Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140.

Authors:  Won-Kyu Lee; Sang Hyeon Son; Bong-Suk Jin; Jung-Hyun Na; Soo-Youl Kim; Kook-Han Kim; Eunice Eunkyeong Kim; Yeon Gyu Yu; Hyung Ho Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

10.  2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.

Authors:  Benoît Bestgen; Irina Kufareva; Weiguang Seetoh; Chris Abell; Rolf W Hartmann; Ruben Abagyan; Marc Le Borgne; Odile Filhol; Claude Cochet; Thierry Lomberget; Matthias Engel
Journal:  J Med Chem       Date:  2019-02-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.